GlassScriptPhysician profile
Cara E Kraus
NPI 1376058594
$15,540.88
in general payments reported to CMS, 2019-2025
46 companies · $3,203 in 2025
The $3,203 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,419 · 2022: $3,072 · 2023: $2,815 · 2024: $3,031 · 2025: $3,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,041 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,040.76 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,672.63 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $2,378.88 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,321.77 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $1,293.43 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $980.29 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $803.96 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $791.19 | 2021-2025 | |
| Amgen INC. | $767.90 | 2021-2025 | Otezla, Repatha, Evenity |
| Merck Sharp & Dohme LLC | $728.64 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $430.68 | 2021-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $408.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $264.83 | 2024-2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $262.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $247.36 | 2021-2024 | |
| Sanofi Pasteur INC. | $236.07 | 2022-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.